Abstract
Background
Acromegaly secondary to growth hormone-releasing hormone (GHRH) excess is rare.
Aims/case description
We report two patients with acromegaly who were diagnosed with sellar gangliocytomas that were immunopositive for GHRH. Tumour tissue persisted after debulking surgery and in the second case this was associated with persistent growth hormone hypersecretion, successfully suppressed by a somatostatin analogue.
Conclusions
The development of functional pituitary adenomas in association with sellar gangliocytomas is poorly understood. We present a brief discussion of the possible aetiology of these unusual pituitary tumours.
References
Agha A, Farrell L, Downey P et al (2004) Acromegaly secondary to growth hormone releasing hormone secretion. Ir J Med Sci 173:215–216. doi:10.1007/BF02914554
Asa SL, Scheithauer BW, Bilbao JM et al (1984) A case for hypothalamic acromegaly: a clinicopathological study of six patients with hypothalamic gangliocytomas producing growth hormone-releasing factor. J Clin Endocrinol Metab 58:796–803
Bevan JS, Asa SL, Rossi ML et al (1989) Intrasellar gangliocytoma containing gastrin and growth hormone-secreting pituitary adenoma. Clin Endocrinol (Oxf) 30:213–224. doi:10.1111/j.1365-2265.1989.tb02229.x
Bloch B, Brazeau P, Ling N et al (1983) Immunohistochemical detection of growth-hormone releasing factor in brain. Nature 301:607. doi:10.1038/301607a0
Geddes JF, Jansen GH, Robinson SFD et al (2000) “Gangliocytomas” of the pituitary: a heterogeneous group of lesions with differing histogenesis. Am J Surg Pathol 24:607–613. doi:10.1097/00000478-200004000-00017
Huang BY, Castillo M (2005) Nonadenomatous tumours of the pituitary and sella turcica. Top Magn Reson Imaging 16:289–299. doi:10.1097/01.rmr.0000224685.83629.18
Isidro ML, Iglesias Diaz P, Matias-Guiu X, Cordido F (2005) Acromegaly due to a growth hormone-releasing hormone-secreting intracranial gangliocytoma. J Endocrinol Invest 28:162–165
Kurosaki M, Saeger W, Ludecke DK (2002) Intrasellar gangliocytomas associated with acromegaly. Brain Tumor Pathol 19:63–67. doi:10.1007/BF02478929
Luna V, Morales F, Luengo LM, Sanz A, Diaz J (2001) Pituitary gangliocytoma-adenoma presenting with acromegaly: response to treatment. Arch Intern Med 161:1010–1011. doi:10.1001/archinte.161.7.1010
Melmed S (2006) Acromegaly. N Engl J Med 355:2558–2573. doi:10.1056/NEJMra062453
Morikawa M, Tamaki N, Kokunai T, Imai Y (1997) Intrasellar pituitary gangliocyto-adenoma presenting with acromegaly: case report. Neurosurgery 40:611–615. doi:10.1097/00006123-199703000-00036
Nasr C, Mason A, Mayberg M, Staugaitis SM, Asa SL (2006) Acromegaly and somatroph hyperplasia with adenomatous transformation due to pituitary metastasis of a growth hormone-releasing hormone-secreting pulmonary endocrine carcinoma. J Clin Endocrinol Metab 91(12):4776–4780. doi:10.1210/jc.2006-0610
Puchner MJA, Ludecke DK, Saeger W, Riedel M, Asa SL (1995) Gangliocytomas of the sellar region: a review. Exp Clin Endocrinol Diabetes 103:129–149
Saeger W, Puchner JA, Ludecke DK (1994) Combined sellar gangliocytoma and pituitary adenoma in acromegaly or Cushing’s disease. Virchows Arch 425:93–99. doi:10.1007/BF00193956
Towfighi J, Salam MM, McLendon RE, Powers S, Page RB (1996) Ganglion cell-containing tumours of the pituitary gland. Arch Pathol Lab Med Online 120:369–377
Acknowledgments
Dr Rachel Crowley is the beneficiary of an unrestricted educational grant from Novo Nordisk.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Crowley, R.K., al-Derazi, Y., Lynch, K. et al. Acromegaly associated with gangliocytoma. Ir J Med Sci 181, 353–355 (2012). https://doi.org/10.1007/s11845-009-0433-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11845-009-0433-2